Andrew N Dauber MD MMSc
Pediatric Growth Disorder Endocrinology
Chief of Endocrinology, Children's National Medical Center
Join to View Full Profile
111 Michigan AveWashington, DC 20010
Phone+1 202-476-2121
Fax+1 202-476-4095
Dr. Dauber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Endocrinology, 2008 - 2011- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2004 - 2008
Harvard Medical SchoolClass of 2004
Certifications & Licensure
DC State Medical License 2018 - 2027
MD State Medical License 2024 - 2026
VA State Medical License 2020 - 2026
MA State Medical License 2006 - 2020
OH State Medical License 2014 - 2019
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age Start of enrollment: 2011 Aug 01
- Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency Start of enrollment: 2018 Feb 01
- Vosoritide for Selected Genetic Causes of Short Stature Start of enrollment: 2020 Aug 04
Publications & Presentations
PubMed
- 1 citationsC-Type Natriuretic Peptide Analogs: Current and Future Therapeutic Applications.Despoina M Galetaki, Andrew Dauber
Hormone Research in Paediatrics. 2025-01-01 - 1 citationsClinical Predictors of Good/Poor Response to Growth Hormone Treatment in Children with Idiopathic Short Stature.Andrew Dauber, Moshe Phillip, Jean-Marc Ferran, Nicky Kelepouris, Navid Nedjatian
Hormone Research in Paediatrics. 2024-11-21 - Treatment of Short Stature in Aggrecan-deficient Patients With Recombinant Human GH: 3-year Response.Gajanthan Muthuvel, Andrew Dauber, Eirene Alexandrou, Leah Tyzinski, Vivian Hwa
Journal of the Endocrine Society. 2024-10-29
Journal Articles
- Gain-of-Function DNMT3A Mutations Cause Microcephalic Dwarfism and Hypermethylation of Polycomb-Regulated RegionsAndrew Dauber, MD, Nature
- DLK1 Is a Novel Link Between Reproduction and MetabolismAndrew Dauber, MD, The Journal of Clinical Endocrinology and Metabolism
- Insights and Implications of Genome Wide Association Studies of HeightAndrew Dauber, MD, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
Breaking Barriers in Growth Disorder Treatment for FamiliesJanuary 14th, 2025
Pharmacokinetic and Pharmacodynamic Analysis of Vosoritide in Phase 2 TrialNovember 18th, 2024
Promising Results After Precision Medicine Trial for Growth Hormone ResistanceMay 30th, 2024- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
